Hovione and Ripple Enter Strategic Partnership to Expand Epidel® Platform into Non-Ophthalmic Space

LISBON, Portugal, March 20, 2023 /PRNewswire/ -- Hovione, the specialist integrated CDMO, leader in spray drying and particle engineering, and Ripple Therapeutics, a leading ophthalmic sustained

Related Keywords

China ,Portugal ,United States ,Lisbon ,Lisboa ,Ireland ,New Jersey ,Wendy Naimark ,Jean Luc Herbeaux ,Prnewswire Hovione ,Ripple Therapeutics Corporation ,Manufacturing Organization ,Technology Officer ,A Contract Development ,Vanessa Romeu Communications ,Chemical Pharmaceutical Company ,Certifiedb Corp ,Ripple Therapeutics ,Chief Technology ,Contract Development ,Pharmaceutical Company ,Therapeutics Corporation ,Communications Director ,Diese Gold Aktie ,Sichern Sie ,Hovione ,Ripple ,Winter ,Strategic ,Partnership ,Xpand ,Spidel ,Platform ,Ophthalmic ,Space ,